Recent Updates
Recently added Catalysts
EQ Positive Sentiment

Equillium to Participate in Upcoming Investor Conferences

Wednesday, September 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Equillium, Inc. announced its participation in two upcoming investor conferences. The Cantor Global Healthcare Conference will feature a fireside chat and one-on-one meetings on September 9, 2026. The H.C. Wainwright 28th Annual Global Investment Conference will include a company presentation and meetings on September 14, 2026. Management will be available for investor interactions.
Price reaction · baseline $2.205 (2026-09-01 close) · hit pre-market · clean, no other EQ news in the window
day 0 close · peak
+2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Equillium is participating in prestigious investor conferences.
  • Management will engage directly with investors through meetings.
  • The company is focused on developing impactful therapies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+3%
120-day peak, hindsight
Typical move
9.5%
average across 6 past catalysts
Cash runway
~40 mo
Minimal dilution risk
Lead asset
EQ001
Phase 1 · Acute-graft-versus-host Disease

Full Press Release Details

LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Cantor Global Healthcare Conference 2026 Format: Fireside Chat & 1x1 Meetings Date: Wednesday, September 9, 2026 Time: 9:45 AM EDT Webcast Link: Here

H.C. Wainwright 28 th Annual Global Investment Conference Format: Company Presentation & 1x1 Meetings Date: Monday, September 14, 2026 Time: 11:00 AM EDT
Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.
A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.
About Equillium Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.
For more information, visit www.equilliumbio.com.

Investor Contact PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 pkelleher@lifesciadvisors.com

Frequently Asked Questions

When will Equillium participate in investor conferences?

Equillium will participate in conferences on September 9 and 14, 2026.

What format will the Cantor Global Healthcare Conference take?

The Cantor conference will feature a fireside chat and one-on-one meetings.

How can investors access the Cantor conference webcast?

Investors can access the webcast on Equillium's Events & Presentations page.

Who can meet with Equillium management at the conferences?

Registered investors attending the conferences can meet with Equillium management.

ShareAdd on Google
Tags: EQ Equillium investor conferences biotechnology autoimmune disorders
Last updated: Sep 2, 2026

Biotech snapshot

Cash runway
$57M liquidity · $1M/mo burn
~40 mo
Minimal dilution risk
Lead asset
EQ001Phase 1
Acute-graft-versus-host Disease →

Catalyst track record

+3%
best trade around EQ's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for EQ.

See every catalyst's timing & PoA →